| URL | https://www.reuters.com/business/healthcare-pharma |
| Source | Reuters |
| Date Published | 04/22/2025 |
| Author Name | John Revill |
| Company/Division name | Roche |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 12000 |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2030 |
| Capital investment ($): | 50000 |
| Country(ies) from which reshored: | Switzerland |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Tariffs |